2.51 USD
+0.02 (+0.8%)
2.51 USD
0 (0%)
Overall QIPT gets a fundamental rating of 3 out of 10. We evaluated QIPT against 100 industry peers in the Health Care Providers & Services industry. QIPT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, QIPT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
QIPT had negative earnings in the past year.
In the past year QIPT had a positive cash flow from operations.
In the past 5 years QIPT reported 4 times negative net income.
Each year in the past 5 years QIPT had a positive operating cash flow.
1.2 Ratios
QIPT has a Return On Assets of -4.35%. This is in the lower half of the industry: QIPT underperforms 66.00% of its industry peers.
The Return On Equity of QIPT (-10.01%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.35% | ||
| ROE | -10.01% | ||
| ROIC | N/A |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
QIPT has a better Gross Margin (71.51%) than 88.00% of its industry peers.
In the last couple of years the Gross Margin of QIPT has remained more or less at the same level.
QIPT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
QIPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for QIPT has been increased compared to 1 year ago.
QIPT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, QIPT has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.38, we must say that QIPT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.38, QIPT is not doing good in the industry: 77.00% of the companies in the same industry are doing better.
QIPT has a debt to FCF ratio of 5.81. This is a neutral value as QIPT would need 5.81 years to pay back of all of its debts.
QIPT has a better Debt to FCF ratio (5.81) than 63.00% of its industry peers.
QIPT has a Debt/Equity ratio of 0.71. This is a neutral value indicating QIPT is somewhat dependend on debt financing.
QIPT's Debt to Equity ratio of 0.71 is in line compared to the rest of the industry. QIPT outperforms 54.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.81 | ||
| Altman-Z | 0.38 |
ROIC/WACCN/A
WACC8.15%
2.3 Liquidity
QIPT has a Current Ratio of 1.15. This is a normal value and indicates that QIPT is financially healthy and should not expect problems in meeting its short term obligations.
QIPT has a Current ratio of 1.15. This is in the lower half of the industry: QIPT underperforms 60.00% of its industry peers.
A Quick Ratio of 0.75 indicates that QIPT may have some problems paying its short term obligations.
QIPT has a Quick ratio of 0.75. This is in the lower half of the industry: QIPT underperforms 79.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.15 | ||
| Quick Ratio | 0.75 |
3. Growth
3.1 Past
The earnings per share for QIPT have decreased strongly by -90.91% in the last year.
The Revenue for QIPT has decreased by -10.21% in the past year. This is quite bad
Measured over the past years, QIPT shows a very strong growth in Revenue. The Revenue has been growing by 32.16% on average per year.
EPS 1Y (TTM)-90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
Revenue 1Y (TTM)-10.21%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-8.88%
3.2 Future
Based on estimates for the next years, QIPT will show a very strong growth in Earnings Per Share. The EPS will grow by 97.77% on average per year.
Based on estimates for the next years, QIPT will show a very strong growth in Revenue. The Revenue will grow by 21.85% on average per year.
EPS Next Y-64.33%
EPS Next 2Y23.79%
EPS Next 3Y2.12%
EPS Next 5Y97.77%
Revenue Next Year-7.25%
Revenue Next 2Y9.25%
Revenue Next 3Y6.7%
Revenue Next 5Y21.85%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
QIPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QIPT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QIPT is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QIPT indicates a rather cheap valuation: QIPT is cheaper than 90.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.85 | ||
| EV/EBITDA | 5.19 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.79%
EPS Next 3Y2.12%
5. Dividend
5.1 Amount
No dividends for QIPT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.51
+0.02 (+0.8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners49.49%
Inst Owner Change-0.26%
Ins Owners15.18%
Ins Owner Change0%
Market Cap109.03M
Revenue(TTM)229.68M
Net Income(TTM)-10.26M
Analysts80
Price Target3.74 (49%)
Short Float %3.16%
Short Ratio3.7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.85%
Min Revenue beat(2)-9.06%
Max Revenue beat(2)-0.65%
Revenue beat(4)0
Avg Revenue beat(4)-8.24%
Min Revenue beat(4)-20.53%
Max Revenue beat(4)-0.65%
Revenue beat(8)0
Avg Revenue beat(8)-5.71%
Revenue beat(12)1
Avg Revenue beat(12)-4.96%
Revenue beat(16)2
Avg Revenue beat(16)-4.19%
PT rev (1m)-0.04%
PT rev (3m)0.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.47 | ||
| P/FCF | 6.85 | ||
| P/OCF | 3.65 | ||
| P/B | 1.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.19 |
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.37
FCFY14.59%
OCF(TTM)0.69
OCFY27.42%
SpS5.29
BVpS2.36
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.35% | ||
| ROE | -10.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.51% | ||
| FCFM | 6.93% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.22%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
F-Score3
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.81 | ||
| Debt/EBITDA | 2 | ||
| Cap/Depr | 33.78% | ||
| Cap/Sales | 6.09% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 81.97% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.15 | ||
| Quick Ratio | 0.75 | ||
| Altman-Z | 0.38 |
F-Score3
WACC8.15%
ROIC/WACCN/A
Cap/Depr(3y)26.65%
Cap/Depr(5y)21.79%
Cap/Sales(3y)4.61%
Cap/Sales(5y)3.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
EPS Next Y-64.33%
EPS Next 2Y23.79%
EPS Next 3Y2.12%
EPS Next 5Y97.77%
Revenue 1Y (TTM)-10.21%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-8.88%
Revenue Next Year-7.25%
Revenue Next 2Y9.25%
Revenue Next 3Y6.7%
Revenue Next 5Y21.85%
EBIT growth 1Y-209.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1642.71%
EBIT Next 3Y181.71%
EBIT Next 5Y154.85%
FCF growth 1Y-39.09%
FCF growth 3Y22.49%
FCF growth 5Y24.98%
OCF growth 1Y-12.62%
OCF growth 3Y23.7%
OCF growth 5Y33.42%
QUIPT HOME MEDICAL CORP / QIPT FAQ
Can you provide the ChartMill fundamental rating for QUIPT HOME MEDICAL CORP?
ChartMill assigns a fundamental rating of 3 / 10 to QIPT.
What is the valuation status of QUIPT HOME MEDICAL CORP (QIPT) stock?
ChartMill assigns a valuation rating of 2 / 10 to QUIPT HOME MEDICAL CORP (QIPT). This can be considered as Overvalued.
Can you provide the profitability details for QUIPT HOME MEDICAL CORP?
QUIPT HOME MEDICAL CORP (QIPT) has a profitability rating of 2 / 10.
Can you provide the financial health for QIPT stock?
The financial health rating of QUIPT HOME MEDICAL CORP (QIPT) is 2 / 10.
What is the expected EPS growth for QUIPT HOME MEDICAL CORP (QIPT) stock?
The Earnings per Share (EPS) of QUIPT HOME MEDICAL CORP (QIPT) is expected to decline by -64.33% in the next year.